These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 687878)

  • 21. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT; Cirtain MC; Look AT; Ashmun RA
    Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The synergistic action of antifertility compounds in the male rat.
    Gilmore DP
    Biol Reprod; 1973 Dec; 9(5):544-8. PubMed ID: 4358342
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative effects of neonatal exposure of male rats to potent and weak (environmental) estrogens on spermatogenesis at puberty and the relationship to adult testis size and fertility: evidence for stimulatory effects of low estrogen levels.
    Atanassova N; McKinnell C; Turner KJ; Walker M; Fisher JS; Morley M; Millar MR; Groome NP; Sharpe RM
    Endocrinology; 2000 Oct; 141(10):3898-907. PubMed ID: 11014247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and SAR of vinca alkaloid analogues.
    Voss ME; Ralph JM; Xie D; Manning DD; Chen X; Frank AJ; Leyhane AJ; Liu L; Stevens JM; Budde C; Surman MD; Friedrich T; Peace D; Scott IL; Wolf M; Johnson R
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1245-9. PubMed ID: 19147348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective effect of Vinca rosea L. alkaloids on type A4 rat spermatogonium.
    Bustos-Obregon E; Lopez ML
    Andrologie; 1973; 5(3):245-7. PubMed ID: 4765055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradoxical risk of reduced fertility after exposure of prepubertal mice to vincristine or cyclophosphamide at low gonadotoxic doses in humans.
    Delessard M; Saulnier J; Dumont L; Rives-Feraille A; Rives N; Rondanino C
    Sci Rep; 2020 Oct; 10(1):17859. PubMed ID: 33082498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocytes and "vinca rosea" alkaloids. An in vitro study.
    Zavagli G; Ricci G; Logallo G
    Nouv Rev Fr Hematol (1978); 1980; 22(4):327-37. PubMed ID: 7255154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.
    Himes RH; Kersey RN; Heller-Bettinger I; Samson FE
    Cancer Res; 1976 Oct; 36(10):3798-802. PubMed ID: 954003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased sensitivity to Vinca alkaloids in cells overexpressing calmodulin by gene transfection.
    Ido M; Lagacé L; Chafouleas JG
    Cancer Res; 1990 Oct; 50(20):6554-8. PubMed ID: 2208115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effects of triptolide on spermatogenesis, epididymal sperm function, and fertility in male rats.
    Huynh PN; Hikim AP; Wang C; Stefonovic K; Lue YH; Leung A; Atienza V; Baravarian S; Reutrakul V; Swerdloff RS
    J Androl; 2000; 21(5):689-99. PubMed ID: 10975416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxicity of vinblastine and vincristine to pancreatic acinar cells.
    Nevalainen TJ
    Virchows Arch B Cell Pathol; 1975; 18(2):119-27. PubMed ID: 807028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Snail neurons as a possible model for testing neurotoxic side effects of antitumor agents: paracrystal formation by Vinca alkaloids.
    Müller LJ; Moorer-van Delft CM; Roubos EW
    Cancer Res; 1988 Dec; 48(24 Pt 1):7184-8. PubMed ID: 3191492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional impairment of the primary nociceptive analyser in the course of transganglionic degenerative atrophy.
    Szücs A; Csillik B; Knyihár-Csillik E
    Acta Biol Hung; 1983; 34(2-3):267-73. PubMed ID: 6198829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New cytoskeletal proteins are induced in HeLa cells by Vinca alkaloids.
    Maehara Y; Kusumoto H; Anai H; Kusumoto T; Sugimachi K
    Oncology; 1988; 45(3):187-91. PubMed ID: 3130596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of cancer chemotherapeutic agents on normal hematopoietic precursor cells: a review.
    Marsh JC
    Cancer Res; 1976 Jun; 36(6):1853-82. PubMed ID: 773531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical and clinical pharmacology of vinca alkaloids.
    Zhou XJ; Rahmani R
    Drugs; 1992; 44 Suppl 4():1-16; discussion 66-9. PubMed ID: 1283846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mutagenic activity of anti-cancer drugs and the urine of rats given these drugs.
    Pak K; Iwasaki T; Miyakawa M; Yoshida O
    Urol Res; 1979 Jun; 7(2):119-24. PubMed ID: 382571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of tripchlorolide on the epididymides and testes of rats.
    Wang ZP; Gu ZP; Cao L; Xu Y; You GD; Mao BY; Qian SZ
    Asian J Androl; 1999 Sep; 1(3):121-5. PubMed ID: 11250778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Vinca Alkaloids on the Expression Levels of microRNAs Targeting Apoptosis-related Genes in Breast Cancer Cell Lines.
    Mavrogiannis AV; Kokkinopoulou I; Kontos CK; Sideris DC
    Curr Pharm Biotechnol; 2018; 19(13):1076-1086. PubMed ID: 30417784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vinca alkaloids: anti-vascular effects in a murine tumour.
    Hill SA; Lonergan SJ; Denekamp J; Chaplin DJ
    Eur J Cancer; 1993; 29A(9):1320-4. PubMed ID: 8343277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.